Whatman plc purchased Schleicher & Schuell MicroScience GmbH, Schleicher & Schuell BioScience GmbH and Schleicher & Schuell GmbH for 50.2 million Euro. The acquisition of Schleicher & Schuell's MicroScience and BioScience business will make Whatman the clear number 3 in the global LabSciences sector with a combined 16% market share. Dr. Werner Specht, CEO of Schleicher & Schuell, said employees and customers of both companies will benefit from the proposed merger.